ES2354618T3 - Composición farmacéutica que comprende besilato de amlodipina y lisinopril dihidrato y procedimiento para su preparación. - Google Patents

Composición farmacéutica que comprende besilato de amlodipina y lisinopril dihidrato y procedimiento para su preparación. Download PDF

Info

Publication number
ES2354618T3
ES2354618T3 ES05751188T ES05751188T ES2354618T3 ES 2354618 T3 ES2354618 T3 ES 2354618T3 ES 05751188 T ES05751188 T ES 05751188T ES 05751188 T ES05751188 T ES 05751188T ES 2354618 T3 ES2354618 T3 ES 2354618T3
Authority
ES
Spain
Prior art keywords
mixture
lisinopril dihydrate
weight
amlodipine besylate
lisinopril
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05751188T
Other languages
English (en)
Spanish (es)
Inventor
Ákos KELEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Nyrt
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Application granted granted Critical
Publication of ES2354618T3 publication Critical patent/ES2354618T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES05751188T 2004-06-10 2005-06-09 Composición farmacéutica que comprende besilato de amlodipina y lisinopril dihidrato y procedimiento para su preparación. Expired - Lifetime ES2354618T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0401170 2004-06-10
HU0401170A HUP0401170A2 (en) 2004-06-10 2004-06-10 Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for

Publications (1)

Publication Number Publication Date
ES2354618T3 true ES2354618T3 (es) 2011-03-16

Family

ID=89985289

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05751188T Expired - Lifetime ES2354618T3 (es) 2004-06-10 2005-06-09 Composición farmacéutica que comprende besilato de amlodipina y lisinopril dihidrato y procedimiento para su preparación.

Country Status (15)

Country Link
EP (1) EP1765342B9 (enExample)
AT (1) ATE486599T1 (enExample)
CY (1) CY1111484T1 (enExample)
DE (1) DE602005024554D1 (enExample)
DK (1) DK1765342T3 (enExample)
EA (1) EA010288B1 (enExample)
ES (1) ES2354618T3 (enExample)
HR (1) HRP20110034T1 (enExample)
HU (2) HUP0401170A2 (enExample)
ME (1) ME01935B (enExample)
PL (1) PL1765342T4 (enExample)
PT (1) PT1765342E (enExample)
RS (1) RS51677B (enExample)
SI (1) SI1765342T1 (enExample)
WO (1) WO2005120502A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2790817A1 (en) * 2010-02-24 2011-09-01 Sanofi-Aventis Deutschland Gmbh Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation
RU2483728C1 (ru) * 2011-09-29 2013-06-10 Общество с ограниченной ответственностью "Озон" Комбинированное гипотензивное средство и способ его получения
PL227900B1 (pl) * 2012-11-15 2018-01-31 Adamed Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję
CN105194647A (zh) * 2014-06-30 2015-12-30 南京瑞尔医药有限公司 一种含有赖诺普利和苯磺酸氨氯地平的药物组合物及其制备方法
CN106333948A (zh) * 2016-08-23 2017-01-18 成都尚药科技有限公司 含有苯磺酸氨氯地平和二水合赖诺普利的药物及制备方法
JP7179758B2 (ja) * 2017-04-25 2022-11-29 大塚製薬株式会社 摂取可能なイベントマーカを有するリシノプリル組成物
GB2595203A (en) 2020-03-03 2021-11-24 Alkaloid Ad Skopje Formulation
CN119730841A (zh) * 2022-09-07 2025-03-28 拉塞·凯那司特 Api含量提高的氨氯地平的立即释放口服药物形式

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11500140A (ja) 1995-03-16 1999-01-06 ファイザー・インコーポレーテッド アムロジピン、アムロジピン塩、もしくはフェロジピンとａｃｅ阻害薬とを含有する組成物
HUP0202416A3 (en) 2002-07-24 2006-01-30 Richter Gedeon Vegyeszet Novel pharmaceutical combination and it's use for the treatment of certain cardiovascular disorders

Also Published As

Publication number Publication date
WO2005120502A1 (en) 2005-12-22
PT1765342E (pt) 2010-12-20
PL1765342T4 (pl) 2022-11-07
DE602005024554D1 (de) 2010-12-16
EA010288B1 (ru) 2008-08-29
CY1111484T1 (el) 2015-08-05
PL1765342T3 (pl) 2011-04-29
EP1765342A1 (en) 2007-03-28
SI1765342T1 (sl) 2011-02-28
HUE009867T2 (enExample) 2011-05-30
EP1765342B9 (en) 2011-02-23
ME01935B (me) 2011-10-31
DK1765342T3 (da) 2011-01-24
HRP20110034T1 (hr) 2011-02-28
HUE009867T4 (hu) 2022-01-28
ATE486599T1 (de) 2010-11-15
HUP0401170A2 (en) 2006-09-28
EA200602187A1 (ru) 2007-04-27
EP1765342B1 (en) 2010-11-03
RS51677B (sr) 2011-10-31
HU0401170D0 (en) 2004-08-30

Similar Documents

Publication Publication Date Title
RU2293555C2 (ru) Аторвастатин кальций в фармацевтической форме, его композиция и фармацевтическая рецептура, содержащая аторвастатин кальций
FI109453B (fi) Farmaseuttinen koostumus
ES2501216T3 (es) Composición farmacéutica que comprende pimobendano
ES2535478T3 (es) Composición farmacéutica
ES2988678T3 (es) Un comprimido que comprende un derivado de metoxiurea y partículas de manitol
US20090324718A1 (en) Imatinib compositions
ES2354618T3 (es) Composición farmacéutica que comprende besilato de amlodipina y lisinopril dihidrato y procedimiento para su preparación.
US8603537B2 (en) Prasugrel containing quickly released stable oral pharmaceutical compositions
ES2483154T3 (es) Formulaciones farmacéuticas sólidas de ramipril y besilato de amlodipino y su preparación
ES2351542T3 (es) Composición farmacéutica que comprende candesartan cilexetilo.
ES2471076T3 (es) Compuestos de inclusión de silodoxina-ciclodextrina
WO2011154009A1 (en) Composition comprising an active principle in an amorphous form and a porous adsorbent material
ES2326214T3 (es) Composiciones orales de 8-cloro-6,11-dihidro-11-(4-piperidiliden)-5h-benzo(5,6)-ciclo-hepta(1,2-b)piridina.
SK5112001A3 (en) A tablet, obtainable by direct compression, comprising the active ingredient 4-amino-1-hydroxybutylidene-1,1-bisphosphonic (alendronic) acid
ES2269787T3 (es) Comprimidos de amlodipino besilato con estabilidad mejorada.
ES2239707T3 (es) Procedimiento de granulacion por via humeda para la preparacion de tabletas farmaceuticas que contienen anhidrato de hidrocloruro de paroxetina.
US20120021054A1 (en) Tablet formulation of ezatiostat
WO2007120930A2 (en) Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives
Narang et al. Drug excipient interactions
ES2380229T3 (es) Formas orales sólidas de ebastina
PT1928425E (pt) Formulação farmacêutica contendo um inibidor de hmg-coa redutase e método para a preparação deste
Mukharya et al. Stable and bio-equivalent formulation of HMG-CoA reductase inhibitor: Atorvastatin Calcium
ES2803430T3 (es) Formulación farmacéutica a base de ibuprofeno y codeína que tiene estabilidad mejorada
ES2313578T3 (es) Formulacion estable que comprende una combinacion de un farmaco sensible a la humedad y un segundo farmaco y procedimiento de preparacion de la misma.
GR1009619B (el) Φαρμακευτικη συνθεση που περιεχει ριβαροξαβανη και μεθοδος για την παρασκευη αυτης